Table 4.

Safety and mortality outcomes

Safety outcomes	N (%)
During CDMT procedure
PE-related death during the procedure	1 (0.9)
Procedure-related death	0 (0)
Major bleeding during procedure	0 (0)
Pulmonary artery injury during procedure	2 (1.8)
Cardiac tamponade during procedure	0 (0)
Clinical deterioration during the procedure	1 (0.9)
Cardiac arrest during the procedure	4 (3.6)
Sustained ventricular tachycardia during the procedure	1 (0.9)
48-h follow-up
PE-related death within 48 h post procedure	4 (3.6)
All-cause death within 48 h post procedure	6 (5.5)
Major bleeding within 48 h post procedure	2 (1.8)
Pulmonary artery injury within 48 h post procedure	2 (1.8)
Cardiac tamponade within 48 h post procedure	0 (0)
Clinical deterioration within 48 h post procedure	1 (0.9)
Infection (pneumonia/sepsis)	16 (14.5)
Stroke (ischaemic/haemorrhagic)	1 (0.9)
30-day follow-up
PE-related mortality within 30 days post procedure	4 (3.6)
All-cause mortality within 30 days post-procedure	9 (8.2)
PE recurrence	0 (0)
90-day follow-up
PE-related mortality within 90 days post procedure	5 (4.5)
All-cause mortality within 90 days post procedure	9 (8.2)
PE recurrence	0 (0)

Abbreviations: See Table 1.